Who
Judd Dayton
Director
Company insider
Files Form 4 as: Director, Lifevantage; Director and 10% owner, Optex Systems Holdings; Chief Executive Officer, FitLife Brands; Director, Otelco; Director, Rlj Entertainment.
In numbers
- Trades disclosed
- 116
- Buys
- 56
- Sells
- 3
- Bought
- $2.2M
- Sold
- $170K
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 20 May 2015
- Last trade
- 2 Mar 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $48K10,500 at $4.53 | filing |
| 2 Mar 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $48K10,500 at $4.53 | filing |
| 27 Feb 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $84K18,097 at $4.63 | filing |
| 27 Feb 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $84K18,097 at $4.63 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $21K4,600 at $4.58 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $21K4,600 at $4.58 | filing |
| 6 Nov 2025filed 10 Nov 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K13,531 at $7.76 | filing |
| 4 Nov 2025filed 6 Nov 2025 | OPXS Optex Systems HoldingsLife-science tools | SEC FORM 4 Code A | $67K4,000 at $16.74 | filing |
| 17 Jun 2025filed 17 Jun 2025 | OPXS Optex Systems HoldingsLife-science tools | SEC FORM 4 Sold | $16K1,800 at $8.95 | filing |
| 16 Jun 2025filed 17 Jun 2025 | OPXS Optex Systems HoldingsLife-science tools | SEC FORM 4 Sold | $131K14,077 at $9.28 | filing |
| 13 Jun 2025filed 17 Jun 2025 | OPXS Optex Systems HoldingsLife-science tools | SEC FORM 4 Sold | $24K2,500 at $9.45 | filing |
| 31 Mar 2025filed 2 Apr 2025 | FTLF FitLife Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —144,000 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Code M | $377K144,000 at $2.62 | filing |
| 30 Dec 2024filed 2 Jan 2025 | FTLF FitLife Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,200 at $0.00 | filing |
| 30 Dec 2024filed 2 Jan 2025 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Code M | $4,3406,200 at $0.70 | filing |
| 7 Nov 2024filed 12 Nov 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $105K7,819 at $13.43 | filing |
| 5 Nov 2024filed 7 Nov 2024 | OPXS Optex Systems HoldingsLife-science tools | SEC FORM 4 Code A | $62K7,600 at $8.10 | filing |
| 26 Feb 2024filed 28 Feb 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $74K12,396 at $6.00 | filing |
| 28 Dec 2023filed 2 Jan 2024 | FTLF FitLife Brandsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,600 at $0.00 | filing |
| 28 Dec 2023filed 2 Jan 2024 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Code M | $6,0208,600 at $0.70 | filing |
News
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)LFVN · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Judd Dayton; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.